NLRP3 and atherosclerosis: BA inhibited macrophage NLRP3 inflammasome via TGR5 signaling-mediated ubiquitination to ameliorate HFD-induced glucose intolerance and insulin resistance, highlighting the coordination of microbiota and immune response to regulate metabolic diseases and further atherosclerosis [201].